With an alphabet soup of credentials– AB, PhD, MD – in fields ranging from medieval studies to experimental pathology, Kush Parmar brings a renaissance view to his work as a principal at 5AM Ventures, an early stage, life science-focused venture capital firm based in California and Massachusetts.
5AM recently made its first investment in Pennsylvania, leading and building a syndicate that led to $23 million in Series A financing for Novira Therapeutics, a Radnor-based, antiviral drug discovery company.
5AM recently made its first investment in Pennsylvania, leading and building a syndicate that led to $23 million in Series A financing for Novira Therapeutics, a Radnor-based, antiviral drug discovery company.